“The effect of APOE and other common genetic variants on the onset of Alzheimer’s disease and dementia: a community-based cohort study,” by Sven J. van der Lee, Frank J. Wolters, M. Kamran Ikram, Albert Hofman, M. Arfan Ikram, Najaf Amin, and Cornelia M. van Duijn (Vol. 17, No. 5, May 2018, p. 434-444).
www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30053-X/abstract
“Innate immune memory in the brain shapes neurological disease hallmarks,” by Ann-Christin Wendeln, Karoline Degenhardt, Lalit Kaurani, Michael Gertig, Thomas Ulas, Gaurav Jain, Jessica Wagner, Lisa M. Hasler, Katleen Wild, Angelos Skodras, Thomas Blank, Ori Staszewski, Moumita Datta, Tonatiuh Pena Centeno, Vincenzo Capece, Md. Rezaul Islam, Cemil Kerimoglu, Matthias Staufenbiel, Joachim L. Schultze, Marc Beyer, Marco Prinz, Mathias Jucker, André Fischer & Jonas J. Neher (Vol. 556, No. 7701, April 19, 2018, p. 332-338).
“Characterizing the human hippocampus in aging and Alzheimer’s disease using a computational atlas derived from ex vivo MRI and histology,” by Daniel H. Adler, Laura E. M. Wisse, Ranjit Ittyerah, John B. Pluta, Song-Lin Ding, Long Xie, Jiancong Wang, Salmon Kadivar, John L. Robinson, Theresa Schuck, John Q. Trojanowski, Murray Grossman, John A. Detre, Mark A. Elliott, Jon B. Toledo, Weixia Liu, Stephen Pickup, Michael I. Miller, Sandhitsu R. Das, David A. Wolk, and Paul A. Yushkevich (Vol. 115, No. 16, April 17, 2018, p. 4252-4257).
A. “Memory deficiency, cerebral amyloid angiopathy, and amyloid-{beta} plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease,” by Diana Klakotskaia, Cansu Agca, Rachel A. Richardson, Edward G. Stopa, Todd R. Schachtman, and Yuksel Agca (PLoS ONE 13(4): e0195469. doi.org/10.1371/journal.pone.0195469, XML, HTML, and .pdf format, 16p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0195469
B. “Inflammatory markers in postoperative delirium (POD) and cognitive dysfunction (POCD): A meta-analysis of observational studies,” by Xuling Liu, Yang Yu, and Shengmei Zhu (PLoS ONE 13(4): e0195659. doi.org/10.1371/journal.pone.0195659, XML, HTML, and .pdf format, p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0195659
Alzheimer’s and Dementia (Vol. 14, No. 4, April 2018).
www.alzheimersanddementia.com/issue/S1552-5260(17)X0006-X
Clinical Gerontologist (Vol. 41, No. 3, 2018).
www.tandfonline.com/toc/wcli20/41/3?nav=tocList&
Dementia (Vol. 17, No. 3, April 2018).
“BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease,” by Jian Bao, Min Qin, Yacoubou Abdoul Razak Mahaman, Bin Zhang, Fang Huang, Kuan Zeng, Yiyuan Xia, Dan Ke, Qun Wang, Rong Liu, Jian-Zhi Wang, Keqiang Ye, and Xiaochuan Wang (Vol. 115, No. 15, April 10, 2018, p. 3954-3959).
“Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease,” by Raffaella Nativio, Greg Donahue, Amit Berson, Yemin Lan, Alexandre Amlie-Wolf, Ferit Tuzer, Jon B. Toledo, Sager J. Gosai, Brian D. Gregory, Claudio Torres, John Q. Trojanowski, Li-San Wang, F. Brad Johnson, Nancy M. Bonini & Shelley L. Berger (Vol. 21, No. 4, April 2018, p. 497-505).
Journal of Alzheimer’s Disease (Vol. 62, No. 4, 2018).
content.iospress.com/journals/journal-of-alzheimers-disease/62/4
“2018 Alzheimer’s Disease Facts and Figures,” (March 2018, .pdf format, 85p.).
American Journal of Alzheimer’s Disease & Other Dementias (Vol. 33, No. 3, May 2018).
journals.sagepub.com/toc/ajae/33/3
Journal of Gerontological Social Work (Vol. 61, No. 3, 2018).
“Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals,” by Heidi I. L. Jacobs, Trey Hedden, Aaron P. Schultz, Jorge Sepulcre, Rodrigo D. Perea, Rebecca E. Amariglio, Kathryn V. Papp, Dorene M. Rentz, Reisa A. Sperling & Keith A. Johnson (Vol. 21, No. 3, March 2018, p. 424-431).
Age and Ageing (Vol. 47, Suppl. 1, March 2018).
academic.oup.com/ageing/issue/47/suppl_1
Alzheimer’s and Dementia: Journal of the Alzheimer’s Association (Vol. 14, No. 3, March 2018).
www.alzheimersanddementia.com/issue/S1552-5260(17)X0005-8
Gerontologist (Vol. 58, No. 2, April 2018).
A. “Susceptibility of brain atrophy to TRIB3 in Alzheimer’s disease, evidence from functional prioritization in imaging genetics,” by Marco Lorenzi, Andre Altmann, Boris Gutman, Selina Wray, Charles Arber, Derrek P. Hibar, Neda Jahanshad, Jonathan M. Schott, Daniel C. Alexander, Paul M. Thompson, Sebastien Ourselin, and for the Alzheimer’s Disease Neuroimaging Initiative (Vol. 115, No. 12, March 20, 2018, p. 3162-3167).
www.pnas.org/content/115/12/3162?etoc=
B. “Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay,” by Andrew D. Nguyen, Thi A. Nguyen, Jiasheng Zhang, Swathi Devireddy, Ping Zhou, Anna M. Karydas, Xialian Xu, Bruce L. Miller, Frank Rigo, Shawn M. Ferguson, Eric J. Huang, Tobias C. Walther, and Robert V. Farese Jr. (Vol. 115, No. 12, March 20, 2018, p. E2849-E2858).
Ageing International (Vol. 43, No. 1, March 2018).
link.springer.com/journal/12126/43/1/page/1
American Journal of Geriatric Psychiatry (Vol. 26, No. 4, April 2018).
www.ajgponline.org/issue/S1064-7481(18)X0003-7
Journal of Alzheimer’s Disease (Vol. 62, No. 3, 2018).
content.iospress.com/journals/journal-of-alzheimers-disease/62/3
Journals of Gerontology (A): Biological Sciences (Vol. 73A, No. 4, April 2018).
International Journal of Aging and Human Development (Vol. 86, No. 3, April 2018).
journals.sagepub.com/toc/ahdb/86/3
Journal of Alzheimer’s Disease (Vol. 62, No. 2, 2018).
content.iospress.com/journals/journal-of-alzheimers-disease/62/2
Journal of Cross-Cultural Gerontology (Vol. 33, No. 1, March 2018).
link.springer.com/journal/10823/33/1/page/1
Journal of Pension Economics (Vol. 17, No. 2, April 2018).
Research on Aging (Vol. 40, No. 4, April 2018).
A. “Epigenetic alterations in longevity regulators, reduced life span, and exacerbated aging-related pathology in old father offspring mice,” by Kan Xie, Devon P. Ryan, Brandon L. Pearson, Kristin S. Henzel, Frauke Neff, Ramon O. Vidal, Magali Hennion, Isabelle Lehmann, Melvin Schleif, Susanne Schröder, Thure Adler, Birgit Rathkolb, Jan Rozman, Anna-Lena Schütz, Cornelia Prehn, Michel E. Mickael, Marco Weiergräber, Jerzy Adamski, Dirk H. Busch, Gerhard Ehninger, Anna Matynia, Walker S. Jackson, Eckhard Wolf, Helmut Fuchs, Valerie Gailus-Durner, Stefan Bonn, Martin Hrabe de Angelis and Dan Ehninger (Vol. 115, No. 10, March 6, 2018, p. E2348-E2357).
doi.org/10.1073/pnas.1707337115
B. “Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity,” by Mariza G. Prado Lima, Helen L. Schimidt, Alexandre Garcia, Letícia R. Daré, Felipe P. Carpes, Ivan Izquierdo and Pâmela B. Mello-Carpes (Vol. 115, No. 10, March 6, 2018, p. E2403-E2408).
A. “Social capital and Internet use in an age-comparative perspective with a focus on later life,” by Barbara Barbosa Neves, Jaime R. S. Fonseca, Fausto Amaro, and Adriano Pasqualotti (PLoS ONE 13(2): e0192119. doi.org/10.1371/journal.pone.0192119, XML, HTML, and .pdf format, 27p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0192119
B. “Analysis of age-related changes in psychosine metabolism in the human brain,” by Michael S. Marshall, Benas Jakubauskas, Wil Bogue, Monika Stoskute, Zane Hauck, Emily Rue, Matthew Nichols, Lisa L. DiAntonio, Richard B. van Breemen, Jeffrey H. Kordower, Carlos A. Saavedra-Matiz, and Ernesto R. Bongarzone (PLoS ONE 13(2): e0193438. doi.org/10.1371/journal.pone.0193438, XML, HTML, and .pdf format, 20p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0193438
A. “Naked mole rats can undergo developmental, oncogene-induced and DNA damage-induced cellular senescence,” by Yang Zhao, Alexander Tyshkovskiy, Daniel Muñoz-Espín, Xiao Tian, Manuel Serrano, Joao Pedro de Magalhaes, Eviatar Nevo, Vadim N. Gladyshev, Andrei Seluanov and Vera Gorbunova (Vol. 115, No. 8, February 20, 2018, p. 1801-1806).
www.pnas.org/content/115/8/1801
B. “NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency,” by Yujun Hou, Sofie Lautrup, Stephanie Cordonnier, Yue Wang, Deborah L. Croteau, Eduardo Zavala, Yongqing Zhang, Kanako Moritoh, Jennifer F. O’Connell, Beverly A. Baptiste, Tinna V. Stevnsner, Mark P. Mattson and Vilhelm A. Bohr (Vol. 115, No. 8, February 20, 2018, p. E1876-E1885).
www.pnas.org/content/115/8/E1876
C. “Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis,” by Xiaopu Zhou, Yu Chen, Kin Y. Mok, Qianhua Zhao, Keliang Chen, Yuewen Chen, John Hardy, Yun Li, Amy K. Y. Fu, Qihao Guo, Nancy Y. Ip and for the Alzheimer’s Disease Neuroimaging Initiative (Vol. 115, No. 8, February 20, 2018, p. 1697-1706)
“Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer’s disease,” by Eleonora M. Lad, Dibyendu Mukherjee, Sandra S. Stinnett, Scott W. Cousins, Guy G. Potter, James R. Burke, Sina Farsiu, and Heather E. Whitson (PLoS ONE 13(2): e0192646. doi.org/10.1371/journal.pone.0192646, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0192646
“High performance plasma amyloid-{beta} biomarkers for Alzheimer’s disease,” by Akinori Nakamura, Naoki Kaneko, Victor L. Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe, Taisuke Tomita, Katsumi Matsuzaki, Kenji Ishii, Kazunari Ishii, Yutaka Arahata, Shinichi Iwamoto, Kengo Ito, Koichi Tanaka, Colin L. Masters & Katsuhiko Yanagisawa (Vol. 554, No. , February 8, 2018, p. 249-254).
A. “Intracellular Ca2+ stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer’s disease,” by Chommanad Lerdkrai, Nithi Asavapanumas, Bianca Brawek, Yury Kovalchuk, Nima Mojtahedi, Maria Olmedillas del Moral and Olga Garaschuk (Vol. 115, No. 6, February 6, 2018, p. E1279-E1288).
www.pnas.org/content/115/6/E1279
B. “Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease,” by Rachel E. Bennett, Ashley B. Robbins, Miwei Hu, Xinrui Cao, Rebecca A. Betensky, Tim Clark, Sudeshna Das and Bradley T. Hyman (Vol. 115, No. 6, February 6, 2018, .pdf and HTML format, p. E1289-E1298). Note: PNAS is providing open access to the full-text of this article.
Journal of Alzheimer’s Disease (Vol. 62, No. 1, 2018).
content.iospress.com/journals/journal-of-alzheimers-disease/62/1
A. “A mathematical model of multisite phosphorylation of tau protein,” by Alexander Stepanov, Tatiana Karelina, Nikolai Markevich, Oleg Demin, and Timothy Nicholas (PLoS ONE 13(2): e0192519. doi.org/10.1371/journal.pone.0192519, XML, HTML, and .pdf format, 17p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0192519
B. “Computational modelling of pathogenic protein spread in neurodegenerative diseases,” by Konstantinos Georgiadis, Selina Wray, Sébastien Ourselin, Jason D. Warren, and Marc Modat (PLoS ONE 13(2): e0192518. doi.org/10.1371/journal.pone.0192518, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0192518
Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association (Vol. 14, No. 2, February 2018).
www.alzheimersanddementia.com/issue/S1552-5260(17)X0004-6
Dementia (Vol. 17, No. 2, February 2018).
journals.sagepub.com/toc/dema/17/2
Gerontologist (Vol. 58, No. 1, February 2018).
academic.oup.com/gerontologist/issue/58/1
Research on Aging (Vol. 40, No. 3, March 2018).
“Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease,” by Lawrence S. Honig, Bruno Vellas, Michael Woodward, Mercè Boada, Roger Bullock, Michael Borrie, Klaus Hager, Niels Andreasen, Elio Scarpini, Hong Liu-Seifert, Michael Case, Robert A. Dean, Ann Hake, Karen Sundell, Vicki Poole Hoffmann, Christopher Carlson, Rashna Khanna, Mark Mintun, Ronald DeMattos, Katherine J. Selzler, and Eric Siemers (Vol. 378, No. 4, January 25, 2018, p. 321-330).
Journal of Alzheimer’s Disease (Vol. 61, No. 4, 2018).
content.iospress.com/journals/journal-of-alzheimers-disease/61/4
American Journal of Alzheimer’s Disease & Other Dementias (Vol. 33, No. 2, March 2018).
A. “Structural heterogeneity and intersubject variability of A{beta} in familial and sporadic Alzheimer’s disease,” by Carlo Condello, Thomas Lemmin, Jan Stöhr, Mimi Nick, Yibing Wu, Alison M. Maxwell, Joel C. Watts, Christoffer D. Caro, Abby Oehler, C. Dirk Keene, Thomas D. Bird, Sjoerd G. van Duinen, Lars Lannfelt, Martin Ingelsson, Caroline Graff, Kurt Giles, William F. DeGrado, and Stanley B. Prusiner (Vol. 115, No. 4, January 23, 2018, .pdf and HTML format, p. E782-E791). Note: PNAS is providing open access to the full-text of this article.
www.pnas.org/content/115/4/E782.abstract
B. “GBA1 deficiency negatively affects physiological {alpha}-synuclein tetramers and related multimers,” by Sangjune Kim, Seung Pil Yun, Saebom Lee, George Essien Umanah, Veera Venkata Ratnam Bandaru, Xiling Yin, Peter Rhee, Senthilkumar S. Karuppagounder, Seung-Hwan Kwon, Hojae Lee, Xiaobo Mao, Donghoon Kim, Akhilesh Pandey, Gabsang Lee, Valina L. Dawson, Ted M. Dawson, and Han Seok Ko (Vol. 115, No. 4, January 23, 2018, p. 798-803).
www.pnas.org/content/115/4/798.abstract
C. “CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation,” by Demetrios G. Vavvas, Kent W. Small, Carl C. Awh, Brent W. Zanke, Robert J. Tibshirani, and Rafal Kustra (Vol. 115, No. 4, January 23, 2018, .pdf and HTML format, p. E696-E704). Note: PNAS is providing open access to the full-text of this article.
A. “The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer’s disease,” by Chun Chen, Zhihao Wang, Zhentao Zhang, Xia Liu, Seong Su Kang, Ying Zhang, and Keqiang Ye (Vol. 115, No. 3, January 16, 2018, p. 578-583).
www.pnas.org/content/115/3/578.abstract
B. “Migration-based selections of antibodies that convert bone marrow into trafficking microglia-like cells that reduce brain amyloid {beta},” by Kyung Ho Han, Britni M. Arlian, Matthew S. Macauley, James C. Paulson, and Richard A. Lerner (Vol. 115, No. 3, January 16, 2018, p. E372-E381). Note: PNAS is providing open-access to the full-text of this article.
A. “Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer’s disease: a cross-sectional study,” by Philip S. J. Weston, Jennifer M. Nicholas, Susie M. D. Henley, Yuying Liang, Kirsty Macpherson, Elizabeth Donnachie, Jonathan M. Schott, Martin N. Rossor, Sebastian J. Crutch, Christopher R. Butler, Adam Z. Zeman, and Nick C. Fox (Vol. 17, No. 2, February 2018, p. 123-132).
www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30434-9/abstract
B. “Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data,” by Jan H. L. Ypinga, Nienke M. de Vries, Lieke H. H. M. Boonen, Xander Koolman, Marten Munneke, Aeilko H. Zwinderman, and Bastiaan R. Bloem (Vol. 17, No. 2, February 2018, p. 153-161).
www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30406-4/abstract
Journal of Alzheimer’s Disease (Vol. 61, No. 3, 2018).
content.iospress.com/journals/journal-of-alzheimers-disease/61/3
Journals of Gerontology (B): Psychological Sciences (Vol. 73B, No. 2, March 2018).
academic.oup.com/psychsocgerontology/issue/73/2
Journal of Pension Economics and Finance (Vol. 17, No. 1, January 2018).
Note: The link below is to the table of contents for the current issue of JAMA (Vol. 319, No. 2, January 2, 2018). Check with your organization’s information center for availability.
jamanetwork.com/journals/jama/issue/319/2
“Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials,” by Alireza Atri, Lutz Frolich, Clive Ballard, Pierre N. Tariot, Jose Luis Molinuevo, Neli Boneva, Kristian Windfeld, Lars L. Raket, and Jeffrey L. Cummings (p. 130-142).
A. “Amyloid-{beta} plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation,” by Zhuohao He, Jing L. Guo, Jennifer D. McBride, Sneha Narasimhan, Hyesung Kim, Lakshmi Changolkar, Bin Zhang, Ronald J. Gathagan, Cuiyong Yue, Christopher Dengler, Anna Stieber, Magdalena Nitla, Douglas A. Coulter, Ted Abel, Kurt R. Brunden, John Q. Trojanowski & Virginia M-Y Lee (Vol. 24, No. 1, January 2018, p. 29-38).
www.nature.com/articles/nm.4443
B. “cGAS drives noncanonical-inflammasome activation in age-related macular degeneration,” by Nagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, Younghee Kim, Dongxu Fu, Ivana Apicella, Akhil Varshney, Reo Yasuma, Benjamin J. Fowler, Elmira Baghdasaryan, Kenneth M. Marion, Xiwen Huang, Tetsuhiro Yasuma, Yoshio Hirano, Vlad Serbulea, Meenakshi Ambati, Vidya L. Ambati, Yuji Kajiwara, Kameshwari Ambati, Shuichiro Hirahara, Ana Bastos-Carvalho, Yuichiro Ogura, Hiroko Terasaki, Tetsuro Oshika, Kyung Bo Kim, David R. Hinton, Norbert Leitinger, John C. Cambier, Joseph D.Buxbaum, M. Cristina Kenney, S. Michal Jazwinski, Hiroshi Nagai, Isao Hara, A. Phillip West, Katherine A. Fitzgerald, SriniVas R. Sadda, Bradley D. Gelfand & Jayakrishna Ambati (Vol. 24, No. 1, January 2018, p. 50-61).
Journal of Aging Studies (Vol. 43, 2017).
www.sciencedirect.com/journal/journal-of-aging-studies/vol/43/suppl/C
Journal of Alzheimer’s Disease (Vol. 61, No. 2, 2017).
content.iospress.com/journals/journal-of-alzheimers-disease/61/2
“Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo,” by Daniel J. Apicco, Peter E. A. Ash, Brandon Maziuk, Chelsey LeBlang, Maria Medalla, Ali Al Abdullatif, Antonio Ferragud, Emily Botelho, Heather I. Ballance, Uma Dhawan, Samantha Boudeau, Anna Lourdes Cruz, Daniel Kashy, Aria Wong, Lisa R. Goldberg, Neema Yazdani, Cheng Zhang, Choong Y. Ung, Yorghos Tripodis, Nicholas M. Kanaan, Tsuneya Ikezu, Pietro Cottone, John Leszyk, Hu Li, Jennifer Luebke, Camron D. Bryant & Benjamin Wolozin (Vol. 21, No. 1, January 2018, p. 72-80).
A. “Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice,” by Noah R. Johnson, Carlo Condello, Shenheng Guan, Abby Oehler, Julia Becker, Marta Gavidia, George A. Carlson, Kurt Giles, and Stanley B. Prusiner (Vol. 114, No. 51, December 19, 2017, p. E11029-E11036).
www.pnas.org/content/114/51/E11029.abstract
B. “Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1,” by D. Cristopher Bragg, Kotchaphorn Mangkalaphiban, Christine A. Vaine, Nichita J. Kulkarni, David Shin, Rachita Yadav, Jyotsna Dhakal, Mai-Linh Ton, Anne Cheng, Christopher T. Russo, Mark Ang, Patrick Acuña, Criscely Go, Taylor N. Franceour, Trisha Multhaupt-Buell, Naoto Ito, Ulrich Müller, William T. Hendriks, Xandra O. Breakefield, Nutan Sharma, and Laurie J. Ozelius (Vol. 114, No. 51, December 19, 2017, p. E11020-E11028). Note: _PNAS_ is providing open access to the full-text of this article.
“Enhancing mitochondrial proteostasis reduces amyloid-{beta} proteotoxicity,” by Vincenzo Sorrentino, Mario Romani, Laurent Mouchiroud, John S. Beck, Hongbo Zhang, Davide D’Amico, Norman Moullan, Francesca Potenza, Adrien W. Schmid, Solene Rietsch, Scott E. Counts & Johan Auwerx (Vol. 552, No. 7684, December 14, 2017, p. 187-193).
www.nature.com/nature/journal/v552/n7684/abs/nature25143.html
Alzheimer’s and Dementia: Journal of the Alzheimer’s Association (Vol. 13, No. 12, December 2017).
www.alzheimersanddementia.com/issue/S1552-5260(16)X0025-8
American Journal of Geriatric Psychiatry (Vol. 26, No. 1, January 2018).
www.ajgponline.org/issue/S1064-7481(16)X0015-2
Journal of Applied Gerontology (Vol. 37, No. 1, January 2018).
journals.sagepub.com/toc/jaga/37/1
Journal of Elder Abuse & Neglect (Vol. 30, No. 1, 2018).
A. “Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease,” by Jay Rasmussen, Jasmin Mahler, Natalie Beschorner, Stephan A. Kaeser, Lisa M. Häsler, Frank Baumann, Sofie Nyström, Erik Portelius, Kaj Blennow, Tammaryn Lashley, Nick C. Fox, Diego Sepulveda-Falla, Markus Glatzel, Adrian L. Oblak, Bernardino Ghetti, K. Peter R. Nilsson, Per Hammarström, Matthias Staufenbiel, Lary C. Walker, and Mathias Jucker (Vol. 114, No. 49, December 5, 2017, p. 13018-13023).
B. “Intercellular competition and the inevitability of multicellular aging,” by Paul Nelson and Joanna Masel (Vol. 114, No. 49, December 5, 2017, p. 12982–12987).
A. “Assemblies of amyloid-{beta}<sub>30–36</sub> hexamer and its G33V/L34T mutants by replica-exchange molecular dynamics simulation,” by Zhenyu Qian, Qingwen Zhang, Yu Liu, and Peijie Chen (PLoS ONE 12(11): e0188794. doi.org/10.1371/journal.pone.0188794, XML, HTML, and .pdf format, 18p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0188794
B. “Elderly emergency patients presenting with non-specific complaints: Characteristics and outcomes,” by Joyce J. H. Wachelder, Patricia M. Stassen, Laura P. A. M. Hubens, Steffie H. A. Brouns, Suze L. E. Lambooij, Jeanne P. Dieleman, and Harm R. Haak (PLoS ONE 12(11): e0188954. doi.org/10.1371/journal.pone.0188954, XML, HTML, and .pdf format, 11p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0188954
C. “Identifying social factors amongst older individuals in linked electronic health records: An assessment in a population based study,” by Anu Jain, Albert J. van Hoek, Jemma L. Walker, Rohini Mathur, Liam Smeeth, and Sara L. Thomas (PLoS ONE 12(11): e0189038. doi.org/10.1371/journal.pone.0189038, XML, HTML, and .pdf format, 17p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0189038
Bulletin of the World Health Organization (Vol. 95, No. 11, November 2017). Note: This is a special edition on Healthy Ageing.
Journal of Alzheimer’s Disease (Vol. 61, No. 1, 2017).
content.iospress.com/journals/journal-of-alzheimers-disease/61/1
Research on Aging (Vol. 40, No. 1, January 2018).
“24-month intervention with a specific multinutrient in people with prodromal Alzheimer’s disease (LipiDiDiet): a randomised, double-blind, controlled trial,” by Hilkka Soininen, Alina Solomon, Pieter Jelle Visser, Suzanne B. Hendrix, Kaj Blennow, Miia Kivipelto, and Tobias Hartmann on behalf of the LipiDiDiet clinical study group (Vol. 16, No. 12, December 2017, p. 965-975).
www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30332-0/abstract
“Oxalate-curcumin–based probe for micro- and macroimaging of reactive oxygen species in Alzheimer’s disease,” by Jian Yang, Xueli Zhang, Peng Yuan, Jing Yang, Yungen Xu, Jaime Grutzendler, Yihan Shao, Anna Moore, and Chongzhao Ran (Vol. 114, No. 47, November 21, 2017, p. 12384-12389).
“Assessing the Preparedness of the U.S. Health Care System Infrastructure for an Alzheimer’s Treatment,” by Jodi L. Liu, Jakub P. Hlavka, Richard Hillestad, and Soeren Mattke (November 2017, .pdf format, 16p.).
European Journal of Ageing (Vol. 14, No. 4, December 2017).
link.springer.com/journal/10433/14/4/page/1
Gerontologist (Vol. 57, No. 6, December 2017).
academic.oup.com/gerontologist/issue/57/6
Journal of Alzheimer’s Disease (Vol. 60, No. 4, 2017).
content.iospress.com/journals/journal-of-alzheimers-disease/60/4
Journal of the American Geriatrics Society (Vol. 65, No. 11, November 2017).
onlinelibrary.wiley.com/doi/10.1111/jgs.2017.65.issue-11/issuetoc
Journals of Gerontology (A): Biological Sciences (Vol. 72A, No. 12, December 2017).
academic.oup.com/biomedgerontology/issue/72/12
Journal of Gerontological Social Work (Vol. 60, No. 8, 2017).
A. “Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer’s disease,” by Tatsuo Mano, Kenichi Nagata, Takashi Nonaka, Airi Tarutani, Tomohiro Imamura, Tadafumi Hashimoto, Taro Bannai, Kagari Koshi-Mano, Takeyuki Tsuchida, Ryo Ohtomo, Junko Takahashi-Fujigasaki, Satoshi Yamashita, Yasumasa Ohyagi, Ryo Yamasaki, Shoji Tsuji, Akira Tamaoka, Takeshi Ikeuchi, Takaomi C. Saido, Takeshi Iwatsubo, Toshikazu Ushijima, Shigeo Murayama, Masato Hasegawa, and Atsushi Iwata (Vol. 114, No. 45, November 7, 2017, .pdf and HTML format, p. E9645–E9654). Note: PNAS is providing open access to the full-text of this article.
www.pnas.org/content/114/45/E9645.abstract
B. “Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer’s disease,” by Robert J. Andrew, Celia G. Fernandez, Molly Stanley, Hong Jiang, Phuong Nguyen, Richard C. Rice, Virginie Buggia-Prévot, Pierre De Rossi, Kulandaivelu S. Vetrivel, Raza Lamb, Arnau Argemi, Emilie S. Allaert, Elle M. Rathbun, Sofia V. Krause, Steven L. Wagner, Angèle T. Parent, David M. Holtzman, and Gopal Thinakaran (Vol. 114, No. 45, November 7, 2017, p. E9665-E9674).
www.pnas.org/content/114/45/E9665.abstract
C. “Individual differences in associative memory among older adults explained by hippocampal subfield structure and function,” by Valerie A. Carr, Jeffrey D. Bernstein, Serra E. Favila, Brian K. Rutt, Geoffrey A. Kerchner, and Anthony D. Wagner (Vol. 114, No. 45, November 7, 2017, p. 12075-12080).
Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association (Vol. 13, No. 11, November 2017).
www.alzheimersanddementia.com/issue/S1552-5260(16)X0024-6
American Journal of Alzheimer’s Disease & Other Dementias (Vol. 32, No. 8, December 2017).
A. “M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory,” by Claude-Henry Volmar, Hasib Salah-Uddin, Karolina J. Janczura, Paul Halley, Guerline Lambert, Andrew Wodrich, Sivan Manoah, Nidhi H. Patel, Gregory C. Sartor, Neil Mehta, Nancy T. H. Miles, Sachi Desse, David Dorcius, Michael D. Cameron, Shaun P. Brothers, and Claes Wahlestedt (Vol. 114, No. 43, October 24, 2017, .pdf and HTML format, p. E9135–E9144). Note: PNAS is providing open access to the full text of this article.
www.pnas.org/content/114/43/E9135.abstract
B. “TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy,” by Cheryl E. G. Leyns, Jason D. Ulrich, Mary B. Finn, Floy R. Stewart, Lauren J. Koscal, Javier Remolina Serrano, Grace O. Robinson, Elise Anderson, Marco Colonna, and David M. Holtzman (Vol. 114, No. 43, October 24, 2017, .pdf and HTML format, p. 11524-11529). Note: PNAS is providing open access to the full text of this article.
A. “Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer’s disease: a longitudinal retrospective study,” by Keith A. Josephs, Dennis W. Dickson, Nirubol Tosakulwong, Stephen D. Weigand, Melissa E. Murray, Leonard Petrucelli, Amanda M. Liesinger, Matthew L Senjem, Anthony J. Spychalla, David S. Knopman, Joseph E. Parisi, Ronald C Petersen, Clifford R. Jack Jr, and Jennifer L. Whitwell (Vol. 16, No. 11, November 2017, p. 917-924).
www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30284-3/abstract
B. “Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson’s disease: a longitudinal cohort study and validation,” by Jeanne C. Latourelle, Michael T. Beste, Tiffany C. Hadzi, Robert E. Miller, Jacob N. Oppenheim, Matthew P. Valko, Diane M. Wuest, Bruce W. Church, Iya G. Khalil, Boris Hayete, and Charles S. Venuto (Vol. 16, No. 11, November 2017, p. 908-916).
www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30328-9/abstract
Powered by WordPress
